The National Eczema Association (NEA), along with Impact Education, LLC and Partners for Advancing Clinical Education (PACE), is cohosting an educational event alongside California AMCP, Advancing Equity: Pediatric Atopic Dermatitis Management in Managed Care. Michele Guadalupe, MPH, NEA's Director of Advocacy and Access, will be speaking at the event in La Jolla, CA, Wednesday, July 17th 6:30pm PT. Learn more: https://lnkd.in/g9s2wfsa #PatientAdvocacy #Eczema #EczemaAdvocacy #AtopicDermatitis #Dermatology #PediatricDermatology #PediatricEczema
National Eczema Association
Non-profit Organizations
Novato, California 4,851 followers
Our vision is a world without eczema.
About us
The National Eczema Association (NEA) is the driving force for an eczema community fueled by knowledge, strengthened through collective action and propelled by the promise for a better future. NEA is a national, patient-oriented organization which is governed by a Board of Directors and guided by a Scientific Advisory Committee comprised of physicians and scientists who donate their time and expertise. NEA is entirely supported through individual and corporate contributions and is a 501(c)(3) tax-exempt organization. NEA receives no federal grants or sub grants, or federal contracts or subcontracts.
- Website
-
http://nationaleczema.org
External link for National Eczema Association
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- Novato, California
- Type
- Nonprofit
- Founded
- 1988
- Specialties
- Eczema, Atopic Dermatitis, and Child eczema
Locations
-
Primary
505 San Marin Drive
Suite B300
Novato, California 94945, US
Employees at National Eczema Association
-
Melody Sugg, CFRE
-
Maisie Wong-Paredes
Partner at M2 Professional Solutions | National Eczema Association Ambassador & Advocate
-
Kristin Belleson, MBA, CAE
-
Jessica Lewis Bartolini
Experienced Patient Advocacy Professional | Program Manager | I plan and lead programs that connect diverse stakeholders, representing the patient…
Updates
-
A new study from the National Eczema Association research team examines barriers that eczema patients and their caregivers face when accessing prescription treatments. Read more findings from the study: https://lnkd.in/gXwcCmJy #EczemaResearch #Eczema #AtopicDermatitis #EczemaTreatment #EczemaMedicine #EczemaCare #AccessToCare #AccessToTreatments #PrescriptionTreatmentAccess #HealthInsurance #EczemaAdvocacy #InsuranceCoverage
-
-
Here are 3 key takeaways from the National Eczema Association’s research on the mental health support eczema patients receive, or don’t receive, from their primary eczema provider. Read more results from the research study: https://lnkd.in/gg84ZFjZ #EczemaResearch #Eczema #AtopicDermatitis #InflammatoryDisease #SkinCondition #ChronicDisease #SkinDisease #EczemaAwareness #MentalHealth #MentalHealthResources #MentalHealthAwareness
-
-
In this episode of Eczema Answered, JiaDe Yu answers the question “Can antibiotics administered during labor and delivery cause an eczema flare?” Listen on our website or search for Eczema Answered on your favorite podcast streaming service: https://lnkd.in/gZChCWR7 #Eczema #AtopicDermatitis #EczemaTreatment #EczemaCare #Antibiotics #ImmuneDiseases #InflammatoryCondition #Inflammation #Antibiotic
-
-
Aashima Gupta tells the story of how she got through her worst eczema flare. Read her story: https://lnkd.in/gaDD9kYZ #Eczema #AtopicDermatitis #EczemaLife #EczemaWarrior #EczemaWarriors #EczemaTravel #EczemaVacation #EczemaFlare
-
-
Treatment options continue to expand for our community! Today the FDA approved Zoryve cream (roflumilast 0.15%), from manufacturer Arcutis Biotherapeutics, for the treatment of mild to moderate atopic dermatitis in adults and children ages 6 and older. Zoryve is available by prescription only. Learn more: https://lnkd.in/gDJTCrbV #EczemaTreatment #EczemaCare #EczemaRelief #EczemaMedications #EczemaTherapies #EczemaManagement #EczemaTopicals #TopicalTreatment #NewTreatment #NovelTherapy
Breaking News: FDA Approves Zoryve Cream (Roflumilast 0.15%) for Atopic Dermatitis -- Zoryve Foam 0.3% was Previously Approved for Seborrheic Dermatitis
google.com
-
You might recognize that little blue symbol — the Seal — on some of your favorite skincare and/or household products, but what exactly does it mean? Read more for a deeper look at what it means to obtain the Seal, including who reviews the products and how companies maintain the Seal standards to help you ensure you’re using quality products for your life with eczema: https://lnkd.in/gFJaXirM #GetEczemaWise #Eczema #AtopicDermatitis #EczemaItch #EczemaRelief #Dermatologist #Dermatology #EczemaTreatment #SealOfAcceptance #EczemaProduct #EczemaFriendly #EczemaCareProduct
-
-
In this episode of S’more Time with the Doc, eczema patient Amanda Lopez and Dr. Zelma Chiesa Fuxench discuss the connection between mental health and eczema. Watch more: https://lnkd.in/gnuyTGJX #GetEczemaWise #SmoreTimeWithTheDoc #UnhideEczema #EczemaCare #EczemaWarriors #AtopicDermatitis #AtopicEczema #Dermatology #EczemaVideo #DoctorPatient #DoctorPatientRelationship
-
Moisturizing can help many of the factors that make atopic dermatitis symptoms worse, including damaged skin barrier, increased skin pH, loss of water in the skin, changes in the microbiome and different factors in the immune system. Read our article on why and how moisturizing is important in eczema care: https://lnkd.in/gvT66yXZ #Eczema #AtopicDermatitis #Dermatologist #Dermatology #EczemaTreatment #EczemaInformation #ManagingItch #SkinBarrier #Moisturizer
-
-
In this online activity, learn how JAK inhibition plays into the treatment of immune-mediated inflammatory diseases (IMIDs) such as atopic dermatitis! Test your knowledge on who might be a good candidate for this therapy and what you should consider to improve your clinical decision making: https://bit.ly/3vKtvPc Produced with our partner, PVI, PeerView Institute for Medical Education. #AtopicDermatitis #JAKInhibitors #InflammatoryDisease #Eczema #EczemaResearch #EczemaTreatment #EczemaTherapy #EczemaMedication #TargetedTreatment
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Diseases: Addressing Shared Pathophysiology With JAK Inhibitors
lrn.peerview.com